The collaboration will see HNL Lab Medicine deploy Ibex’s cutting-edge AI solution, Ibex Prostate, for biopsies and transurethral resection of the prostate (TURP), boosting both diagnostic accuracy and workflow efficiency
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
The quarter included three IPOs worth US$ 428 million and one Qualified Institutional Placement (QIP) worth US$ 88 million
Subscribe To Our Newsletter & Stay Updated
